More than two decades after graduating from the UT College of Fine Arts, Ramón H. Rivera-Servera will become the first Latino dean of the College of Fine Arts starting July 1.
To honor May as Mental Health Awareness Month, The Daily Texan has compiled tips on balancing news consumption while maintaining a healthy state of mind.
While UT is planning for a “near normal” fall semester, student organizations have had trouble during the past year filling leadership positions and keeping membership numbers and engagement high.
Students are calling for University President Jay Hartzell to rescind his support for a Texas State Senate bill which will allocate between $3 million and $6 million sometime between 2022 and 2023 for the development of a campus “Liberty Institute.”
UT scientists have discovered a previously unidentified group of microbial organisms that can break down dead matter without releasing greenhouse gases.
The Daily Texan spoke to the filmmakers of short film "Frankie" about making the film and the future of transgender and nonbinary people in the entertainment industry.
A man loading a gun crashed an online meeting hosted by the service organization Texas Orange Jackets discussing the origins of “The Eyes of Texas” on April 29. Members said the violent incident reveals the situation with UT’s alma mater is “higher stakes” than some may think.
A year-long grant from Blue Cross and and Blue Shield of Texas will allow UT nutrition experts to develop a new digital platform that gives local teachers access to outdoor instructional resources, according to an April 16 press release.
In 2018, the UT System endowment fund grew to be the second-largest in the country with about $30 billion in funds. Now, UT System experts have broken down how this money is used and collected.
Certain common nervous system cells can change their function to facilitate blood vessel repair and recovery after a stroke, potentially paving the way for new brain injury treatments, according to an April 27 study by UT researchers.
Drugs approved to treat hepatitis C could boost the efficacy of the only antiviral approved to combat COVID-19 by as much as tenfold when administered together, according to a paper co-authored by a UT researcher.
A UT program at Dell Medical School is working to bring accessible treatment to people with substance and opioid use disorder during acute hospitalization, or short-term inpatient medical care.
